AY BI DI TERAPEVTIKS, OOO, Moscow

Economic indicators

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO dropped over 2024 by 18.54% to 3.20 million RUB from 3.93 million RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold decreased 2.06 times to 167.00 thousand RUB from 344.00 thousand RUB; sales loss decreased by 26.47% to 1.61 million RUB from 2.20 million RUB.

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO increased 2.63 times to 3.93 million RUB from 1.50 million RUB over 2022, the company informed.

Cost of goods sold grew 86.00 times to 344.00 thousand RUB from 4.00 thousand RUB; sales loss grew 4.66 times to 2.20 million RUB from 471.00 thousand RUB.

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO increased by 19.84% to 1.50 million RUB from 1.25 million RUB over 2021, the company informed.

Sales loss decreased by 15.59% to 471.00 thousand RUB from 558.00 thousand RUB.

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO increased 1.59 times to 1.25 million RUB from 788.00 thousand RUB over 2020, the company informed.

Sales loss grew 1.73 times to 558.00 thousand RUB from 323.00 thousand RUB.

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO dropped over 2020 by 39.80% to 788.00 thousand RUB from 1.31 million RUB KAgent.Entities.Balance, the company informed.

Sales loss decreased 3.15 times to 323.00 thousand RUB from 1.02 million RUB.

Net loss (RAS) of AY BI DI TERAPEVTIKS, OOO increased 7.11 times to 1.31 million RUB from 184.00 thousand RUB over 2018, the company informed.

Sales loss grew 17.55 times to 1.02 million RUB from 58.00 thousand RUB.

Companies in the region

• AL'TAIR
• SERVIS-M
• ZOLOTAYA RYBKA
• KVOLITI ES
• PONDERA-INDUSTRI